Cargando…
First person – Emily Koller
First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Emily Koller is first author on ‘ Temporal and spatially controlled APP transgene expressio...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Company of Biologists Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9150104/ http://dx.doi.org/10.1242/dmm.049602 |
_version_ | 1784717353231056896 |
---|---|
collection | PubMed |
description | First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Emily Koller is first author on ‘ Temporal and spatially controlled APP transgene expression using Cre-dependent alleles’, published in DMM. Emily is a postdoctoral associate in the lab of Joanna Jankowsky, PhD at Baylor College of Medicine, Houston, TX, USA, investigating the impact of ageing in Alzheimer's disease, and is also interested in developing therapeutic interventions for diseases of the brain. |
format | Online Article Text |
id | pubmed-9150104 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | The Company of Biologists Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-91501042022-05-31 First person – Emily Koller Dis Model Mech First Person First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Emily Koller is first author on ‘ Temporal and spatially controlled APP transgene expression using Cre-dependent alleles’, published in DMM. Emily is a postdoctoral associate in the lab of Joanna Jankowsky, PhD at Baylor College of Medicine, Houston, TX, USA, investigating the impact of ageing in Alzheimer's disease, and is also interested in developing therapeutic interventions for diseases of the brain. The Company of Biologists Ltd 2022-05-16 /pmc/articles/PMC9150104/ http://dx.doi.org/10.1242/dmm.049602 Text en © 2022. Published by The Company of Biologists Ltd https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed. |
spellingShingle | First Person First person – Emily Koller |
title | First person – Emily Koller |
title_full | First person – Emily Koller |
title_fullStr | First person – Emily Koller |
title_full_unstemmed | First person – Emily Koller |
title_short | First person – Emily Koller |
title_sort | first person – emily koller |
topic | First Person |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9150104/ http://dx.doi.org/10.1242/dmm.049602 |